Article
Author(s):
Washington-As Congress moves toward possible approval of a new prescriptiondrug program for Medicare recipients later this summer, determination ofpayments for cancer drugs and therapeutic services may well hang in thebalance.
Coding Q&A: How to bill for second-generation stone device
Health policy in urology: 2024 AUA Advocacy Summit recap
Money Matters: How to cope with market volatility in 2025
How APPs can bridge the gap in urologist shortages
Level of service for vasectomy prompts coding confusion
Trends in urology: Arpeet Shah, MD, on challenges and opportunities in 2025